$ALL Balance Sheet | Understand Stock

$ALL

$255.53 +$2.34 (0.92%) Live

$ALL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Financial Position

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Investments
Fixed income securities, at fair value (amortized cost, net $38,811 and $40,034)
Fixed income securities, at fair value (amortized cost, net $60,902 and $58,730)
Equity securities, at fair value (cost $10,071 and $8,026)
Mortgage loans, net
Limited partnership interests
Short-term, at fair value (amortized cost $4,874 and $4,888)
Other investments, net
Total investments

Cash
Premium installment receivables, net
Deferred policy acquisition costs
Reinsurance and indemnification recoverables, net
Accrued investment income
Deferred income taxes
Property and equipment, net
Goodwill
Other assets, net
Assets held for sale
Total assets
Liabilities
Reserve for property and casualty insurance claims and claims expense
Reserve for future policy benefits
Contractholder funds
Unearned premiums
Claim payments outstanding
Deferred income taxes
Other liabilities and accrued expenses
Debt
Liabilities held for sale
Total liabilities
Equity
Preferred stock and additional capital paid-in, $1 par value, 25 million shares authorized, 82.0 thousand shares issued and outstanding, $2,050 aggregate liquidation preference
Common stock, $.01 par value, 2.0 billion shares authorized and 900 million issued, 254 million and 260 million shares outstanding
Additional capital paid-in
Retained income
Treasury stock, at cost (624 million and 619 million shares)
Treasury stock, at cost (646 million and 640 million shares)
Accumulated other comprehensive income (loss):
Unrealized net capital gains and losses
Unrealized foreign currency translation adjustments
Unamortized pension and other postretirement prior service credit
Discount rate for reserve for future policy benefits
Total accumulated other comprehensive (loss) income
Total Allstate shareholders’ equity
Noncontrolling interest
Total equity

Total liabilities and equity
Common stock, shares outstanding (in shares)
Treasury stock, shares (in shares)

Comments